PURPOSE: Epigenetic alterations including changes to cellular DNA methylation levels contribute to carcinogenesis and may serve as powerful biomarkers of the disease. This investigation sought to determine whether hypomethylation at the long interspersed nuclear elements (LINE1), reflective of the level of global DNA methylation, in peripheral blood-derived DNA is associated with increased risk of bladder cancer. EXPERIMENTAL DESIGN: LINE1 methylation was measured from blood-derived DNA obtained from participants of a population-based incident case-control study of bladder cancer in New Hampshire. Bisulfite-modified DNA was pyrosequenced to determine LINE1 methylation status; a total of 285 cases and 465 controls were evaluated for methylation. RESULTS: Being in the lowest LINE1 methylation decile was associated with a 1.8-fold increased risk of bladder cancer [95% confidence interval (95% CI), 1.12-2.90] in models controlling for gender, age, and smoking, and the association was stronger in women than in men (odds ratio, 2.48; 95% CI, 1.19-5.17 in women; and odds ratio, 1.47; 95% CI, 0.79-2.74 in men). Among controls, women were more likely to have lower LINE1 methylation than men (P = 0.04), and levels of arsenic in the 90th percentile were associated with reduced LINE1 methylation (P = 0.04). CONCLUSIONS: LINE1 hypomethylation may be an important biomarker of bladder cancer risk, especially among women.
PURPOSE: Epigenetic alterations including changes to cellular DNA methylation levels contribute to carcinogenesis and may serve as powerful biomarkers of the disease. This investigation sought to determine whether hypomethylation at the long interspersed nuclear elements (LINE1), reflective of the level of global DNA methylation, in peripheral blood-derived DNA is associated with increased risk of bladder cancer. EXPERIMENTAL DESIGN: LINE1 methylation was measured from blood-derived DNA obtained from participants of a population-based incident case-control study of bladder cancer in New Hampshire. Bisulfite-modified DNA was pyrosequenced to determine LINE1 methylation status; a total of 285 cases and 465 controls were evaluated for methylation. RESULTS: Being in the lowest LINE1 methylation decile was associated with a 1.8-fold increased risk of bladder cancer [95% confidence interval (95% CI), 1.12-2.90] in models controlling for gender, age, and smoking, and the association was stronger in women than in men (odds ratio, 2.48; 95% CI, 1.19-5.17 in women; and odds ratio, 1.47; 95% CI, 0.79-2.74 in men). Among controls, women were more likely to have lower LINE1 methylation than men (P = 0.04), and levels of arsenic in the 90th percentile were associated with reduced LINE1 methylation (P = 0.04). CONCLUSIONS: LINE1 hypomethylation may be an important biomarker of bladder cancer risk, especially among women.
Authors: D M Sassaman; B A Dombroski; J V Moran; M L Kimberland; T P Naas; R J DeBerardinis; A Gabriel; G D Swergold; H H Kazazian Journal: Nat Genet Date: 1997-05 Impact factor: 38.330
Authors: M R Karagas; T A Stukel; J S Morris; T D Tosteson; J E Weiss; S K Spencer; E R Greenberg Journal: Am J Epidemiol Date: 2001-03-15 Impact factor: 4.897
Authors: Jane C Figueiredo; Maria V Grau; Kristin Wallace; A Joan Levine; Lanlan Shen; Randala Hamdan; Xinli Chen; Robert S Bresalier; Gail McKeown-Eyssen; Robert W Haile; John A Baron; Jean-Pierre J Issa Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-03-31 Impact factor: 4.254
Authors: C O Abernathy; Y P Liu; D Longfellow; H V Aposhian; B Beck; B Fowler; R Goyer; R Menzer; T Rossman; C Thompson; M Waalkes Journal: Environ Health Perspect Date: 1999-07 Impact factor: 9.031
Authors: Hui-Chen Wu; Qiao Wang; Lissette Delgado-Cruzata; Regina M Santella; Mary Beth Terry Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-06-04 Impact factor: 4.254
Authors: Haley L Cash; Stephen T McGarvey; E Andrés Houseman; Carmen J Marsit; Nicola L Hawley; Geralyn M Lambert-Messerlian; Satupaitea Viali; John Tuitele; Karl T Kelsey Journal: Epigenetics Date: 2011-10-01 Impact factor: 4.528
Authors: L H Lumey; Mary Beth Terry; Lissette Delgado-Cruzata; Yuyan Liao; Qiao Wang; Ezra Susser; Ian McKeague; Regina M Santella Journal: Int J Epidemiol Date: 2011-09-29 Impact factor: 7.196
Authors: Dana van Bemmel; Petra Lenz; Linda M Liao; Dalsu Baris; Lawrence R Sternberg; Andrew Warner; Alison Johnson; Michael Jones; Masatoshi Kida; Molly Schwenn; Alan R Schned; Debra T Silverman; Nathaniel Rothman; Lee E Moore Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-04-26 Impact factor: 4.254
Authors: Gabriella Andreotti; Sara Karami; Ruth M Pfeiffer; Lauren Hurwitz; Linda M Liao; Stephanie J Weinstein; Demetrius Albanes; Jarmo Virtamo; Debra T Silverman; Nathaniel Rothman; Lee E Moore Journal: Epigenetics Date: 2013-12-06 Impact factor: 4.528
Authors: Lissette Delgado-Cruzata; Hui-Chen Wu; Yuyan Liao; Regina M Santella; Mary Beth Terry Journal: Epigenetics Date: 2013-10-29 Impact factor: 4.528
Authors: Scott M Langevin; E Andres Houseman; Brock C Christensen; John K Wiencke; Heather H Nelson; Margaret R Karagas; Carmen J Marsit; Karl T Kelsey Journal: Epigenetics Date: 2011-07-01 Impact factor: 4.528
Authors: Isabelle R Miousse; Marie-Cecile G Chalbot; Annie Lumen; Alesia Ferguson; Ilias G Kavouras; Igor Koturbash Journal: Mutat Res Rev Mutat Res Date: 2015-05-30 Impact factor: 5.657
Authors: Julia Mendoza-Pérez; Jian Gu; Luis A Herrera; Nizar M Tannir; Surena F Matin; Jose A Karam; Maosheng Huang; David W Chang; Christopher G Wood; Xifeng Wu Journal: Clin Cancer Res Date: 2015-12-11 Impact factor: 12.531